Multi-spectral quantum dot-based retinal imaging of molecular expression in vivo
基于多光谱量子点的体内分子表达视网膜成像
基本信息
- 批准号:7192344
- 负责人:
- 金额:$ 19.17万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-03-01 至 2010-02-28
- 项目状态:已结题
- 来源:
- 关键词:Acridine OrangeAdhesionsAnimal Disease ModelsAnimal ModelAntibodiesArteriesAsthmaAtherosclerosisBindingBiologicalBiological MarkersBloodBlood CirculationBlood PlateletsBlood VesselsCD31 AntigensCell Adhesion MoleculesCell Culture SystemCell membraneCell surfaceCellsCharacteristicsCodeComplexCultured CellsCytotoxic T-LymphocytesDetectionDevelopmentDiabetes MellitusDiagnosticDiagnostic ProcedureDiseaseDisease ProgressionDyesE-SelectinEarly identificationEndothelial CellsEndotheliumEtiologyEventExtravasationEyeFluorescenceFluorescence MicroscopyFluorescent ProbesImageImaging TechniquesImmune responseIn VitroIndividualInflammationInflammation MediatorsInflammatoryInflammatory ResponseInjection of therapeutic agentIntercellular adhesion molecule 1InvasiveLabelLaboratoriesLeukocyte RollingLeukocyte TraffickingLeukocytesMalignant NeoplasmsMediator of activation proteinMethodologyMethodsMicrocirculationModalityModelingMolecularMolecular ProbesMonitorMonoclonal AntibodiesNanotechnologyNoiseNumbersOpticsPathologyPharmaceutical PreparationsPlayPolymersPopulationProcessPropertyProtein EngineeringQuantum DotsRadiolabeledRattusRelative (related person)ResearchResistanceResolutionRetinaRetinalRoleSignal TransductionSiteSourceSpecificitySpeedStreptozocinSurfaceSurface AntigensT-LymphocyteTechniquesTechnologyTherapeuticTherapeutic InterventionTimeTissuesTracerTreatment EfficacyTumor AntigensUp-RegulationValidationVascular Cell Adhesion Molecule-1VeinsWorkangiogenesisantibody conjugatebasecell typecharge coupled device cameraconceptdesigndesirediabeticdiabetic ratfluorescence imagingfluorescence microscopefluorophoreimmunogenicityin vivointercellular cell adhesion moleculeinterestlight intensitymolecular dynamicsmolecular imagingmonocytenanocrystalnanoprobeneutrophiloptical imagingquantumradiotracerresearch studyresidenceresponsesizesurface coatingtime usetissue preparationtooluptakevascular inflammation
项目摘要
DESCRIPTION (provided by applicant): Undesirable provocation of the inflammatory response is a detrimental feature of numerous diseases such as diabetes, atherosclerosis, and asthma and thus impacts a significant population. Current strategies utilized to identify key markers of inflammatory disease at the cellular and molecular level have often been centered on in vitro cell culture studies or analyses of tissue excised from animal models of disease. In this proposal we describe the development of a platform for the real-time, in vivo analysis of multiple cellular and molecular mediators of inflammation in diseased animal models using quantum dot nanocrystals and retinal fluorescence microscopy. Our design differs from previous approaches to study inflammation in vivo in that it is enabled by the harnessing of unique and highly-desirable optical properties conferred to quantum dots. These properties include higher quantum efficiency relative to conventional dyes, a resistance to fading, narrow and size-tunable emission spectra all excitable by one wavelength, and amenability to surface engineering of proteins and polymers for optimum stability and targeting. The second enabling technology is our laboratory expertise in in vivo retinal fluorescence imaging which provides unique continuous optical accessibility to the in vivo vasculature. To validate the potential of our proposed technique, in Aim 1 we seek to optimize an imaging modality / nanoprobe design to simultaneously detect the therapeutically-significant biomarkers of inflammation ICAM-1, VCAM-1, PECAM-1, and E-selectin, and to observe their relative molecular expression levels in the retinal vasculature in a rat model of diabetes. Furthermore, we seek to adapt the probe/fluorescence imaging design established in Aim 1 to track multiple leukocyte subsets in real time in vivo in the same animal model. Our preliminary work demonstrates the potential of this technique for the specific labeling and in vivo detection of the endothelial surface markers ICAM-1, VCAM-1 and PECAM-1 in vivo, as well as moving, in vivo-labeled neutrophils in the retinal circulation, with high spatial and temporal resolution and high signal to background ratios. A highlight of our preliminary studies was the first in vivo validation of VCAM-1 and ICAM-1 upregulation in diabetes. This technology has the potential to elucidate complex, cellular and molecular events as they occur in real-time not only in inflammation, but in other diseases such as cancer and ocular disorders as well.
描述(由申请人提供):炎症反应的不良挑衅是许多疾病(例如糖尿病,动脉粥样硬化和哮喘)的有害特征,从而影响了大量人群。当前用于鉴定细胞和分子水平上炎症性疾病关键标记的策略通常以体外细胞培养研究或从动物疾病动物模型中切除的组织分析为中心。在此提案中,我们描述了使用量子点纳米晶体和视网膜荧光显微镜在患病动物模型中对实时,体内分析炎症多个细胞和分子介质的平台的发展。我们的设计与以前研究体内炎症的方法有所不同,因为它可以利用与量子点赋予的独特且高度可取的光学特性来实现。这些特性包括相对于常规染料的较高的量子效率,一种对褪色,狭窄且可调的发射光谱的抗性,所有波长都可以通过一个波长进行激发,以及蛋白质和聚合物表面工程的适应性,以实现最佳稳定性和靶向。第二种促成技术是我们在体内视网膜荧光成像方面的实验室专业知识,它为体内脉管系统提供了独特的连续光学可访问性。为了验证我们提出的技术的潜力,在AIM 1中,我们试图优化成像方式 /纳米探针设计,以同时检测炎症ICAM-1,VCAM-1,PECAM-1,PECAM-1和E-选择性的治疗性生物标志物,并观察其相对分子表达在视网膜脉络膜中的相对分子表达水平。此外,我们试图适应AIM 1中建立的探针/荧光成像设计,以在同一动物模型中实时跟踪多个白细胞子集。我们的初步工作证明了该技术对内皮表面标志物的特定标记和体内检测的潜力,体内ICAM-1,VCAM-1和PECAM-1和PECAM-1在体内以及在视网膜循环中移动,体内标记的中性粒细胞,具有高空间和时间分辨率和高信号和高度信号和高度信号。我们初步研究的亮点是糖尿病中VCAM-1和ICAM-1上调的体内验证。该技术不仅在炎症中,而且在其他疾病(例如癌症和眼部疾病)中实时发生,因此有可能阐明复合物,细胞和分子事件。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(2)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Frederick R Haselton其他文献
Frederick R Haselton的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Frederick R Haselton', 18)}}的其他基金
Urine TB diagnostic by amplicon reconstruction for PCR detection of DNA fragments
通过扩增子重建进行 DNA 片段 PCR 检测诊断尿结核
- 批准号:
10385847 - 财政年份:2021
- 资助金额:
$ 19.17万 - 项目类别:
Point-of-Care RT-PCR System to Inform COVID-19 and Respiratory Illness Decisions
护理点 RT-PCR 系统可为 COVID-19 和呼吸道疾病决策提供信息
- 批准号:
10688237 - 财政年份:2020
- 资助金额:
$ 19.17万 - 项目类别:
Retinal Imaging of Prognostic Indicators of Atherosclerosis
动脉粥样硬化预后指标的视网膜成像
- 批准号:
7573116 - 财政年份:2009
- 资助金额:
$ 19.17万 - 项目类别:
Retinal Imaging of Prognostic Indicators of Atherosclerosis
动脉粥样硬化预后指标的视网膜成像
- 批准号:
7787531 - 财政年份:2009
- 资助金额:
$ 19.17万 - 项目类别:
Development of DNA Logic Operations for Viral Diagnostics
用于病毒诊断的 DNA 逻辑运算的开发
- 批准号:
7573152 - 财政年份:2009
- 资助金额:
$ 19.17万 - 项目类别:
Development of DNA Logic Operations for Viral Diagnostics
用于病毒诊断的 DNA 逻辑运算的开发
- 批准号:
7797468 - 财政年份:2009
- 资助金额:
$ 19.17万 - 项目类别:
Multi-spectral quantum dot-based retinal imaging of molecular expression in vivo
基于多光谱量子点的体内分子表达视网膜成像
- 批准号:
7351806 - 财政年份:2007
- 资助金额:
$ 19.17万 - 项目类别:
Multi-spectral quantum dot-based retinal imaging of molecular expression in vivo
基于多光谱量子点的体内分子表达视网膜成像
- 批准号:
7583895 - 财政年份:2007
- 资助金额:
$ 19.17万 - 项目类别:
Lagrangian detection of biomolecular interactions
生物分子相互作用的拉格朗日检测
- 批准号:
6763620 - 财政年份:2004
- 资助金额:
$ 19.17万 - 项目类别:
Lagrangian detection of biomolecular interactions
生物分子相互作用的拉格朗日检测
- 批准号:
6869526 - 财政年份:2004
- 资助金额:
$ 19.17万 - 项目类别:
相似国自然基金
载Pexidartinib的纳米纤维膜通过阻断CSF-1/CSF-1R通路抑制巨噬细胞活性预防心脏术后粘连的研究
- 批准号:82370515
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
促细胞外囊泡分泌的绒毛膜纳米纤维仿生培养体系的构建及其在宫腔粘连修复中的应用研究
- 批准号:32301204
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
泛素连接酶SMURF2通过SMAD6-COL5A2轴调控宫腔粘连纤维化的分子机制研究
- 批准号:82360301
- 批准年份:2023
- 资助金额:31 万元
- 项目类别:地区科学基金项目
负载羟基喜树碱的双层静电纺纳米纤维膜抑制肌腱粘连组织增生的作用和相关机制研究
- 批准号:82302691
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
活血通腑方调控NETs干预术后腹腔粘连组织纤维化新途径研究
- 批准号:82374466
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
相似海外基金
Reagentless Sensor Technologies For Continuous Monitoring of Heart Failure Biomarkers
用于连续监测心力衰竭生物标志物的无试剂传感器技术
- 批准号:
10636089 - 财政年份:2023
- 资助金额:
$ 19.17万 - 项目类别:
Developing non-immunosuppressive immune-based therapeutics for targeted treatment of autoimmune diseases
开发非免疫抑制性免疫疗法来靶向治疗自身免疫性疾病
- 批准号:
10586562 - 财政年份:2023
- 资助金额:
$ 19.17万 - 项目类别:
Amnion membrane organ-on-chip for modeling intra-amniotic infection
用于模拟羊膜内感染的羊膜器官芯片
- 批准号:
10372321 - 财政年份:2022
- 资助金额:
$ 19.17万 - 项目类别:
Elucidation of Arvcf-dependent mechanisms required for lens function
阐明晶状体功能所需的 Arvcf 依赖性机制
- 批准号:
10615869 - 财政年份:2022
- 资助金额:
$ 19.17万 - 项目类别:
Alterations of leukocyte integrin signaling leading to diabetes and autoimmunity
白细胞整合素信号的改变导致糖尿病和自身免疫
- 批准号:
10502136 - 财政年份:2022
- 资助金额:
$ 19.17万 - 项目类别: